Natural Product: NPC605339

Natural Product IDNPC605339
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
PTHKHRXTRBUUGO-JMHCWUSJSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL354262
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey PTHKHRXTRBUUGO-JMHCWUSJSA-N
Standard InCHI InChI=1S/C22H30O5/c1-13-8-6-9-14(2)12-17(25-16(4)23)18-15(3)21(24)26-19(18)20-22(5,27-20)11-7-10-13/h9-10,17-20H,3,6-8,11-12H2,1-2,4-5H3/b13-10+,14-9+/t17-,18+,19-,20+,22+/m0/s1
SMILES C=C1C(=O)O[C@H]2[C@H]1[C@@H](OC(C)=O)C/C(C)=C/CC/C(C)=C/CC[C@@]1(C)O[C@H]21

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   374.21 Volume:   394.168
?
Van der Waals volume.
Dense:   0.949 LogP:   3.316
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.182
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.906
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   2.0 Rigid Bonds:   23.0
TPSA:   65.13
?
Topological Polar Surface Area.
H-Bond Acceptor:   5.0
H-Bond Donor:   0.0 Rings:   3.0
Heavy Atoms:   5.0

MedChem Properties

QED Drug-Likeness Score:   0.3 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.944 Fsp3:   0.636
MCE-18:   53.667
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Rejected
Golden Triangle Rule:   Rejected BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.477 Fluc inhibitor:   0.006
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.012
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.029
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.491 Promiscuous compounds:   0.352

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -4.78 MDCK Permeability:   -4.817
Pgp-inhibitor:   0.999 Pgp-substrate:   0.003
PAMPA:   0.005
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.002
20% Bioavailability (F20%):   0.029 30% Bioavailability (F30%):   0.533
50% Bioavailability (F50%):   0.903

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.909
Plasma Protein Binding (PPB):   82.532% Volume Distribution (VD):   -0.064
Fu: 13.748%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.005
BSEP inhibitor:   1.0

ADMET: Metabolism

CYP1A2-inhibitor:   0.097 CYP1A2-substrate:   0.311
CYP2C19-inhibitor:   0.368 CYP2C19-substrate:   0.003
CYP2C9-inhibitor:   0.038 CYP2C9-substrate:   0.018
CYP2D6-inhibitor:   0.03 CYP2D6-substrate:   0.023
CYP3A4-inhibitor:   0.008 CYP3A4-substrate:   0.917
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.989
HLM stability:   0.937
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  9.062 Half-life (T1/2):  1.052

ADMET: Toxicity

hERG Blockers:  0.014 hERG Blockers (10um):  0.07
Human Hepatotoxicity (H-HT):  0.497 Drug-induced Liver Injury (DILI):  0.784
AMES Toxicity:  0.214 Rat Oral Acute Toxicity:  0.073
Maximum Recommended Daily Dose:  0.108 Skin Sensitization:  0.987
Carcinogencity:  0.198 Eye Corrosion:  0.262
Eye Irritation:  0.969 Respiratory Toxicity:  0.016
Drug-induced Neurotoxicity:  0.106 Ototoxicity:  0.288
Hematotoxicity:  0.287 Drug-induced Nephrotoxicity:  0.441
Genotoxicity:  0.051 RPMI-8226 Immunitoxicity:  0.052
A549 Cytotoxicity:  0.033 Hek293 Cytotoxicity:  0.168
BCF:   1.602
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.385
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.278
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   5.747
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO27251 Lobophytum crassum Species Alcyoniidae Eukaryota n.a. south china sea n.a. PMID[18512986]
NPO27251 Lobophytum crassum Species Alcyoniidae Eukaryota n.a. n.a. n.a. PMID[18973388]
NPO27251 Lobophytum crassum Species Alcyoniidae Eukaryota n.a. n.a. n.a. PMID[9548852]
NPO27251 Lobophytum crassum Species Alcyoniidae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO27251 Lobophytum crassum Species Alcyoniidae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT29071 Protein complex Geranylgeranyl transferase type I Homo sapiens IC50 = 5300.0 nM DOI[10.1016/0960-894X(96)00142-4]
NPT29670 Protein complex Protein farnesyltransferase Homo sapiens Ki = 170.0 nM DOI[10.1016/0960-894X(96)00142-4]
NPT29670 Protein complex Protein farnesyltransferase Homo sapiens IC50 = 150.0 nM DOI[10.1016/0960-894X(96)00142-4]
NPT29670 Protein complex Protein farnesyltransferase Homo sapiens Inhibition = 26.0 % DOI[10.1016/0960-894X(96)00142-4]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC605339 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9149 High Similarity NPC151770
0.7963 Intermediate Similarity NPC483718
0.7069 Intermediate Similarity NPC288876
0.6607 Remote Similarity NPC481994
0.6491 Remote Similarity NPC481908
0.6491 Remote Similarity NPC481993
0.6296 Remote Similarity NPC38468
0.6296 Remote Similarity NPC192678
0.6296 Remote Similarity NPC319795
0.6296 Remote Similarity NPC50362
0.6296 Remote Similarity NPC488056
0.6296 Remote Similarity NPC605079
0.6226 Remote Similarity NPC93213
0.6038 Remote Similarity NPC171204
0.6038 Remote Similarity NPC606745
0.5965 Remote Similarity NPC5130
0.5862 Remote Similarity NPC272814
0.5667 Remote Similarity NPC481801
0.5593 Remote Similarity NPC483976
0.5484 Remote Similarity NPC485393
0.5397 Remote Similarity NPC475748
0.5397 Remote Similarity NPC264477
0.5357 Remote Similarity NPC611318
0.5345 Remote Similarity NPC49342
0.5345 Remote Similarity NPC251385
0.5238 Remote Similarity NPC231889
0.5238 Remote Similarity NPC483935
0.5172 Remote Similarity NPC256273
0.5167 Remote Similarity NPC608845
0.5088 Remote Similarity NPC207188
0.5079 Remote Similarity NPC212486
0.5077 Remote Similarity NPC481805

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC605339 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.6296 Remote Similarity NPD1733 Clinical (unspecified phase)

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data